Repare Therapeutics, a pharmaceutical startup based in Montreal and Boston, has raised $89.66 million in venture capital to fund the development of new cancer treatments. The investment round was led by Versant and Boston-based MPM. Two Canadian investors — BDC Capital’s Healthcare Venture Fund and Fonds de solidarité FTQ.